Basic fibroblast growth factor (bFGF), which promotes neovascularization and bone remodeling [17–20], is clinically used to treat intractable skin ulcers, tympanic perforation, and alveolar bone defects caused by periodontitis [20–24]. The gene discussed is FGF2; the disease is periodontitis.